On June 22, 2021, Kazakhstan’s second COVID-19 vaccine QazCoVac-P (subunit) was officially included in the list of candidate vaccines of the World Health Organization for conducting phase 1/2 clinical trials.


Earlier, on June 18, 2021, the design of the clinical trial was officially posted on the website ClinicalTrials.gov under Identifier number: NCT04930003



By admin